Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus Lozenges in Low-grade Oral Dysplasia
NCT05707702Phase 3Withdrawn
- Sponsor
- Boston Medical Center
- Start
- Apr 2024
- Primary completion
- Nov 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of FLORASSIST Oral Hygiene in Oral epithelial dysplasia (OED), sponsored by Boston Medical Center. Planned start Apr 2024; status: withdrawn.
02
Drugs
FLORASSIST Oral Hygiene
03
Conditions
Oral epithelial dysplasia (OED)
Beyond the preview
Go deeper on NCT05707702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05707702.